Quercetin in COPD: A Multi-Target Approach to Modulate Inflammation, Oxidative Stress, and Epithelial Dysfunction

Area of Science:

• Biochemistry
• Pharmacology
• Pulmonology

Background:

• Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder affecting millions worldwide.
• Current COPD therapies manage symptoms but don't address underlying causes like oxidative stress and inflammation.
• Oxidative stress and inflammation, driven by environmental factors, are key contributors to COPD development.

Purpose of the Study:

• To review the biological properties of quercetin.
• To explore quercetin's potential therapeutic role in managing COPD.
• To compare quercetin's benefits against existing COPD treatments.

Main Methods:

• Literature review of quercetin's antioxidant and anti-inflammatory mechanisms.
• Analysis of preclinical COPD models investigating quercetin's effects.
• Compilation of research on quercetin's epigenetic and antiviral activities.

Main Results:

• Quercetin exhibits potent antioxidant and anti-inflammatory effects by scavenging reactive oxygen species and modulating inflammatory pathways.
• Preclinical studies show quercetin reduces COPD hallmarks: oxidative stress, lung inflammation, goblet cell metaplasia, and MMP expression.
• Quercetin promotes airway epithelium regeneration and attenuates viral replication, relevant to COPD pathogenesis.

Conclusions:

• Quercetin possesses significant antioxidant, anti-inflammatory, epigenetic, and antiviral properties.
• Quercetin demonstrates therapeutic potential for COPD by targeting root causes beyond symptom management.
• Further research into quercetin may offer novel treatment strategies for COPD.